Devices › Wire, guide, catheter
Device brand name · Wire guide catheter
Amplatz Super Stiff: medical device reports filed with FDA
658 reports name it, 2006–2026. Manufacturer given most often on reports: Boston Scientific. Product code DQX.
- 658
- device reports naming the brand
- 0% of all MAUDE reports · about 32 a year
- 50
- reports, 12 months to August 2026
- 65 in the 12 months before
- 77.1%
- classified as malfunction
- 57.4% across the product code
- 4.7%
- classified as death, as reported
- 31 reports · not verified by FDA
FDA's MAUDE database holds 658 reports that name the brand "Amplatz Super Stiff" (wire guide catheter), received between April 2006 and August 2026; the manufacturer given most often on reports is Boston Scientific. Spellings of one product vary from report to report.
50 reports arrived in the 12 months to August 2026, down 23% from 65 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (77.1%), injury (17.9%) and death (4.7%); across all wire, guide, catheter reports (product code DQX) death is recorded in 2.8% and malfunction in 57.4%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are detachment of device or device component (16.3%), unraveled material (13.5%) and entrapment of device (12.9%). The patient problems coded most often are no patient involvement, pericardial effusion and cardiac perforation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 33,838 reports carrying product code DQX. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Detachment of device or device componentpart of the device came off | 107 | 16.3% | 5.8% |
| Unraveled material | 89 | 13.5% | 3.4% |
| Entrapment of device | 85 | 12.9% | 5% |
| Material integrity problema problem with the device material | 72 | 10.9% | 1.8% |
| Breakthe device broke | 62 | 9.4% | 11.4% |
| Difficult to removethe device was hard to remove | 54 | 8.2% | 15.4% |
| Difficult to advance | 37 | 5.6% | 4.6% |
| Fracturea broken bone | 37 | 5.6% | 7.8% |
| Material deformation | 34 | 5.2% | 2% |
| Detachment of device component | 33 | 5% | 9.3% |
| Peeled/delaminated | 32 | 4.9% | 7.1% |
| Device damaged prior to usethe device was damaged before use | 17 | 2.6% | 0.7% |
| Device contamination with chemical or other material | 11 | 1.7% | 0.4% |
| Bent | 9 | 1.4% | 0.6% |
| Stretched | 9 | 1.4% | 3.8% |
| Unsealed device packaging | 9 | 1.4% | 0.2% |
| Device-device incompatibility | 8 | 1.2% | 0.1% |
| Material separation | 8 | 1.2% | 10.4% |
| Failure to advance | 7 | 1.1% | 4.8% |
| Insufficient device problem information | 7 | 1.1% | 1.6% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 41 | 6.2% |
| Pericardial effusionfluid around the heart | 31 | 4.7% |
| Cardiac perforation | 23 | 3.5% |
| Hemorrhage/blood loss/bleeding | 18 | 2.7% |
| Cardiac tamponade | 15 | 2.3% |
| Deaththe patient died; cause not stated by this term | 15 | 2.3% |
| Foreign body in patientpart of a device left in the patient | 14 | 2.1% |
| Low blood pressure/ hypotension | 14 | 2.1% |
| Device embedded in tissue or plaque | 9 | 1.4% |
| Perforation | 8 | 1.2% |
| Perforation of vessels | 8 | 1.2% |
| Cardiac arrestthe heart stopped | 7 | 1.1% |
| Sepsisa severe body-wide response to infection | 6 | 0.9% |
| Painpain, site not specified | 5 | 0.8% |
| Blood loss | 3 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Amplatz Super Stiff | Product code DQX | All MAUDE reports |
|---|---|---|---|
| Reports | 658 | 33,838 | 26,136,888 |
| Share of that pool | — | 1.9% | 0% |
| Classified as death, per 1,000 reports | 47 | 28 | 9 |
| Classified as injury | 17.9% | 38.9% | 36.2% |
| Classified as malfunction | 77.1% | 57.4% | 62.3% |
| Filed by the manufacturer | 93.9% | 88.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DQX
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| V-18 Control Wire | 554 | 47 | 0.7% |
| Hi-Torque Balance Middleweight Universal Guide Wire | 479 | 0 | 1.3% |
| Starter guidewire | 422 | 179 | 1.2% |
| Amplatz Super Stiff Guidewire | 403 | 0 | 3% |
| Acs Hi-Torque Balance Middleweight Guide Wire | 380 | 0 | 3.2% |
| Arrow Ra Cath Set 22 Ga X 1-3/8 | 346 | 0 | 0% |
| Radifocus Glidewire | 330 | 25 | 2.1% |
| V-14 Controlwire | 325 | 0 | 0.3% |
| Pt | 322 | 13 | 4% |
| V-14? Control Wire? | 305 | 25 | 0.3% |
| Acs Hi-Torque Balance Middleweight Guide Wire With Hydrocoat Hydrophilic Coating | 304 | 0 | 1.3% |
| Guide Wires | 374 | 0 | 1.6% |
| Runthrough Ns | 259 | 0 | 1.9% |
| Hi-Torque Pilot Guide Wire | 256 | 0 | 4.3% |
| Hi-Torque Command 18 Guide Wire | 245 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Amplatz Super Stiff reports
How many FDA reports name Amplatz Super Stiff?
658 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 50 in the latest 12 months.
What kinds of events are reported?
malfunction (77.1%), injury (17.9%) and death (4.7%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
detachment of device or device component (16.3%), unraveled material (13.5%), entrapment of device (12.9%), material integrity problem (10.9%) and break (9.4%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (93.9%) and voluntary reports (2.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Amplatz Super Stiff was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.